To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

Quarterly results

rupeeShow figures in :
rupeeShow figures in :

Quarterly results

Quarter ended on June 30, 2025Data in Crores of INR
Revenue
3.18K+11.16% from last year
Operating profits
995.00+7.22% from last year
Net income
548.00+19.91% from last year

Financial reports

Data is unavailable

INCOME STATEMENTinfo2
Data in Crores of INR

Data is unavailable

BALANCE SHEETinfo2
Data in Crores of INR
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009
Net worth7590.696856.156198.075952.955837.174823.224724.354622.194350.133494.102490.561902.431421.931193.831022.40830.98650.89
Fixed assets7946.908138.118121.456422.657064.637533.127747.717854.683688.442859.082832.66875.34819.82796.87635.55541.15511.25
Debt3026.093937.425297.304018.104825.465840.036038.106462.322510.132351.682740.351131.76692.97578.73572.05522.40482.60
docView detailed balance sheet
arrow
CASH FLOWinfo2
Data in Crores of INR
FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013FY2012FY2011FY2010FY2009
Operating2585.113266.082368.131802.992005.351392.911798.08894.151008.842742.12810.20599.42153.48499.13395.01287.00257.90
Investing -540.05-167.90-2415.31-196.63-449.42198.61-241.28-4706.95-786.91-837.85-2162.30-355.81-241.70-136.97-232.60-128.71-39.58
Financing -2297.99-2779.6477.36-1781.05-1650.79-1549.04-1314.453417.39-192.91-1435.151212.2586.4019.73-192.74-67.61-5.25-18.23

Financial ratios

Profitability ratiosinfo2
ROA13.23%
ROE26.46%
ROCE27.32%
EPS56.47%
Net profit margin16.6%
Operating profit margin22.22%
Dividend per share32%
Operational ratiosinfo2
Quick ratio0.66%
Current ratio1.19%
Interest coverage11.59%
Assets turnover1.17%
Debt to equity0.4%
Valuation ratiosinfo2
P/E ratio63.1%
P/B ratio15.52%
Dividend yield0.86%
EV/EBITDA
Torrent Pharmaceuticals Limited has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM.
personal

Grow your wealth with more research recommendations

+91